Core Scientific Q1 2024 GAAP EPS $0.78 May Not Compare To $0.08 Estimate, Sales $179.300M Beat $154.667M Estimate
Portfolio Pulse from Benzinga Newsdesk
Core Scientific reported its Q1 2024 GAAP EPS at $0.78, significantly surpassing the estimated $0.08. Additionally, its sales reached $179.3M, beating the forecast of $154.667M.
May 08, 2024 | 8:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Core Scientific's Q1 2024 earnings report showed a substantial beat on both EPS and sales estimates, indicating strong financial performance.
The significant outperformance in both earnings per share (EPS) and sales compared to analyst estimates typically leads to positive investor sentiment and could result in a short-term price increase for CORZ. The substantial beat on EPS, especially, indicates operational efficiency and profitability that could attract more investors.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100